#$%^&*AU2018226521B220191031.pdf#####Abstract CYTOMEGALOVIRUS ANTIGENS AND USES THEREOF This disclosure provides modified cytomegalovirus (CMV) gL proteins and complexes comprising gL proteins. The modified gL proteins remain intact and are able to form complexes with other CMV proteins.